AKT1 and prostate cancer: A study in prostate cancer cells revealed that MSA treatment results in decreased expression of genes involved in metabolism, angiogenesis, certain transcription factors and, interestingly, signal transduction (ERK and AKT), which was significantly higher in tumor cells than in non-tumor cells.40